The higher 14-day mortality rate for patients with Acinetobacter bacteremia receiving tigecycline appropriately compared to other appropriate antibiotics (36.4% versus 14.2%, P = 0.028) was due to the poor effect of tigecycline for isolates with a minimum inhibitory concentration of 2 mug/mL (63.6% of 11 versus 14.2% of 127, P = 0.001).
Date:
2018-02
Relation:
Journal of Microbiology, Immunology, and Infection. 2018 Feb;51(1):148-152.
